Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 90OTHER_GOV 3INDUSTRY 2NETWORK 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Stress Disorders, Post-Traumatic 1Sleep Initiation and Maintenance Disorders 1Sleep Disorders, Circadian Rhythm 1Sleep Deprivation 1REM Sleep Behavior Disorder 1Psychological Well-Being 1Pain 1Leukemia 1Idiopathic Hypersomnia 1Depression 1Combat Disorders 1Chronobiology Disorders 1Cancer Pain 1Anxiety Disorders 1Alzheimer Disease 1

Interventions

pembrolizumab 1019Carboplatin 959Paclitaxel 932Gemcitabine 793Cisplatin 748Docetaxel 682Bevacizumab 610Pemetrexed 502Nivolumab 486Cyclophosphamide 466Capecitabine 461Fluorouracil 417Dexamethasone 402Rituximab 372Oxaliplatin 347Injections 342atezolizumab 297Trastuzumab 297Leucovorin 286Cetuximab 282Irinotecan 266130-nm albumin-bound paclitaxel 252Prednisone 244Doxorubicin 240Ipilimumab 226Lenalidomide 220Fulvestrant 217fludarabine 214durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Propofol × Clear all
NCT06644573 2025-05-28

PSHW

PROSOMNIA Sleep Health & Wellness

Phase 1 Not yet recruiting
100 enrolled

Cancer Pain, Psychological Well-Being, Alzheimer Disease, Anxiety Disorders, Combat Disorders, Depression, Sleep Initiation and Maintenance Disorders, Pain, Sleep Deprivation, Stress Disorders, Post-Traumatic, Idiopathic Hypersomnia, Sleep Disorders, Circadian Rhythm, REM Sleep Behavior Disorder, Chronobiology Disorders

NCT01326078 2014-03-26

Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures.

CristĂĄlia Produtos QuĂ­micos FarmacĂȘuticos Ltda.

Phase 2/3 Withdrawn
Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡